Healthcare Innovation October 18, 2024
Mark Hagland

The recent stumbles of the national pharmacy chains offer important insights

As Contributing Editor Geert De Lombaerde reported on Oct. 18, the Woonsocket, Rhode Island-based CVS Health announced that it was replacing its CEO. De Lombaerde’s report began thus: “CVS Corp. president and Chief Executive Officer Karen Lynch stepped down from her job Oct. 17 to be replaced by the leader of the company’s Caremark pharmacy benefit manager. In announcing the change at the helm—which comes just a few months after Lynch shuffled some senior leadership roles and took charge of CVS’ Aetna insurance group—Rhode Island-based CVS also said its third-quarter results will come in well below expectations because of higher-than-expected benefit costs, a trend that first surfaced in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article